Well Chromadex with its super heavy hitter investors in essence has unlimited funds to fight EH. In addition Dartmouth, Cornell, University of California all will spend whatever necessary to defend their patents they have licensed to CDXC. Wonder what the EH investors are thinking about their predicament.
News 
Market Data 
Discover 
